Influence of Dapagliflozin on Glycemic Variations in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Objectives. To observe changes in blood glycemic variations and oxidative stress level before and after dapagliflozin treatment in patients with newly diagnosed T2DM. Methods. This was a randomized, double-blind, placebo-controlled, phase 3 trial. A total of 28 patients with newly diagnosed T2DM wit...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Diabetes Res
Egile Nagusiak: Li, Feng-fei, Gao, Gu, Li, Qian, Zhu, Hong-hong, Su, Xiao-fei, Wu, Jin-dan, Ye, Lei, Ma, Jian-hua
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2016
Gaiak:
Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5050380/
https://ncbi.nlm.nih.gov/pubmed/27738639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/5347262
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak